[Integrations](https://spiral.ai/integrations) › [Codex](https://spiral.ai/integrations/codex) › [EMA medicines under evaluation](https://spiral.ai/integrations/codex/ema-medicines-under-evaluation)

# How to Use EMA medicines under evaluation in Codex

Returns entries from EMA's monthly list of new human medicines under CHMP evaluation, including substance names and evaluation details. Use it to research the application pipeline before an opinion or authorization appears.

|  |  |
| --- | --- |
| Model | EMA medicines under evaluation |
| Available through | Alexandria |
| Category | Health |
| Price | $0.00873 per call. |
| Returns | json |
| Runs | In the background |
| Setup | About 2 minutes, no API key |

## Prompts to try with EMA medicines under evaluation in Codex

- Use EMA medicines under evaluation to look this up and give me the result as a table. Save the result in ./assets.
- Pull the latest numbers from EMA medicines under evaluation and tell me what changed since last week.
- Check EMA medicines under evaluation and summarize what you find in three bullet points.
- Pull the newest data from EMA medicines under evaluation and give me the result as a table.
- Check EMA medicines under evaluation every morning and tell me only when something changed.

## How to set up EMA medicines under evaluation in Codex

Pick the way that suits you. Each takes about two minutes.

### Use Spiral's MCP server

1. **Add the hosted server**

```bash
codex mcp add spiral --url https://api.spiral.ai/mcp
```

2. **Sign in**: Codex opens the browser: sign in to Spiral and click Authorize. No API key. `codex mcp list` then shows Spiral.

```bash
codex mcp login spiral
```

### Use the Spiral skill

1. **Send Codex this message**: Your agent reads Spiral's skill and sets itself up.

```
set up https://spiral.ai/SKILL.md
```

2. **Sign in or paste a key**: Approve Spiral in the browser, or give the agent a key from the console.

### Use the Spiral CLI

1. **Install and sign in**: Installs the Spiral CLI, signs you in and adds its skill to your coding agents.

```bash
npx -y spiral-cli@latest init
```

### Call the Spiral API

1. **Create an API key**: In the console, under API keys.

2. **Run EMA medicines under evaluation**: One request; the result comes back by polling or a webhook.

```bash
curl https://api.spiral.ai/v1/runs \
  -H "Authorization: Bearer $SPIRAL_API_KEY" \
  -H "Content-Type: application/json" \
  -H "Idempotency-Key: $(uuidgen)" \
  -d '{
    "provider": "alexandria",
    "model": "ema-europa-eu/records/applications",
    "input": {
      "limit": 10
    }
  }'
```

Then paste one of the prompts above: Codex finds EMA medicines under evaluation on Spiral, shows the price and runs it.

Setup guide in the docs: https://spiral.ai/docs/quickstarts/codex

## EMA medicines under evaluation tools and prices

- [European Medicines Agency · Applications](https://spiral.ai/tools/alexandria/ema-europa-eu/records/applications) (Alexandria): $0.00873 per call.

## Settings you can ask for

| Setting | Allowed values | Default | Description |
| --- | --- | --- | --- |
| limit | 1 to 25 | 10 | limit |
| month |  | — | Month of the list, YYYY-MM; defaults to the latest. A month without a spreadsheet list is not_found. Pattern: ^[0-9]{4}-[0-9]{2}$. |
| query |  | — | Words that must all appear, case-insensitive, in the INN, therapeutic area (lists before 2025) or product number, e.g. abatacept. |
| cursor |  | — | next_cursor from a previous page with the same filters. Pattern: ^[0-9]{1,6}$. |
| orphan |  | — | true: only designated orphan medicines. |
| ema_product_number |  | — | Only this application, e.g. EMEA/H/C/006877. Not on the list is not_found. Pattern: ^EMEA/[HV]/C/[0-9]{6}$. |

## What can you do with EMA medicines under evaluation in Codex?

Build a regulatory research view that connects EMA records by medicine, substance, or product number. A coding agent can turn returned statuses, dates, and source links into searchable tables in your project.

### Prepare a monthly regulatory briefing

Summarize new applications, scientific opinions, medicine status changes, revised documents, orphan designations, and EMA-assessed shortages. Give each development its own source link and regulatory stage.

### Map a rare disease treatment landscape

Build a condition-specific research table covering designated substances, applications under evaluation, scientific outcomes, authorized products, supporting documents, and reported supply issues.

### Check a pharmaceutical portfolio before a partnership review

Research a public list of products and substances for pending evaluations, committee outcomes, authorization records, orphan status, assessment documents, and published shortage notices.

### Populate a medicine research portal

Create separate views for the application pipeline, scientific opinions, medicine records, documents, orphan designations, and shortages. Link related records by product number where supplied and retain each source's status wording.

### Compare monthly development snapshots

Compare successive application lists for selected substances and review available opinions and orphan designation records to investigate changes in the publicly reported pipeline.

## Overview

- [Alexandria](https://spiral.ai/providers/alexandria)
- [All Codex guides](https://spiral.ai/integrations/codex)

## EMA medicines under evaluation in other agents

- [Amp](https://spiral.ai/integrations/amp/ema-medicines-under-evaluation)
- [ChatGPT](https://spiral.ai/integrations/chatgpt/ema-medicines-under-evaluation)
- [Claude](https://spiral.ai/integrations/claude-desktop/ema-medicines-under-evaluation)
- [Claude Code](https://spiral.ai/integrations/claude-code/ema-medicines-under-evaluation)
- [Cline](https://spiral.ai/integrations/cline/ema-medicines-under-evaluation)
- [Cursor](https://spiral.ai/integrations/cursor/ema-medicines-under-evaluation)
- [Devin](https://spiral.ai/integrations/devin/ema-medicines-under-evaluation)
- [dots](https://spiral.ai/integrations/dots/ema-medicines-under-evaluation)
- [Factory Droid](https://spiral.ai/integrations/factory-droid/ema-medicines-under-evaluation)
- [Gemini](https://spiral.ai/integrations/gemini/ema-medicines-under-evaluation)
- [Gemini CLI](https://spiral.ai/integrations/gemini-cli/ema-medicines-under-evaluation)
- [Google Antigravity](https://spiral.ai/integrations/antigravity/ema-medicines-under-evaluation)
- [goose](https://spiral.ai/integrations/goose/ema-medicines-under-evaluation)
- [Grok](https://spiral.ai/integrations/grok/ema-medicines-under-evaluation)
- [Grok Build](https://spiral.ai/integrations/grok-build/ema-medicines-under-evaluation)
- [Hermes](https://spiral.ai/integrations/hermes/ema-medicines-under-evaluation)
- [Instinct](https://spiral.ai/integrations/instinct/ema-medicines-under-evaluation)
- [Manus](https://spiral.ai/integrations/manus/ema-medicines-under-evaluation)
- [Muse](https://spiral.ai/integrations/muse/ema-medicines-under-evaluation)
- [Muse Code](https://spiral.ai/integrations/muse-code/ema-medicines-under-evaluation)
- [n8n](https://spiral.ai/integrations/n8n/ema-medicines-under-evaluation)
- [Notion](https://spiral.ai/integrations/notion/ema-medicines-under-evaluation)
- [OpenClaw](https://spiral.ai/integrations/openclaw/ema-medicines-under-evaluation)
- [opencode](https://spiral.ai/integrations/opencode/ema-medicines-under-evaluation)
- [Perplexity](https://spiral.ai/integrations/perplexity/ema-medicines-under-evaluation)
- [Raycast](https://spiral.ai/integrations/raycast/ema-medicines-under-evaluation)
- [VS Code](https://spiral.ai/integrations/vscode/ema-medicines-under-evaluation)
- [Windsurf](https://spiral.ai/integrations/windsurf/ema-medicines-under-evaluation)
- [Zapier](https://spiral.ai/integrations/zapier/ema-medicines-under-evaluation)

## More Codex guides

- [EMA medicine shortages](https://spiral.ai/integrations/codex/ema-medicine-shortages)
- [EMA orphan drug designations](https://spiral.ai/integrations/codex/ema-orphan-drug-designations)
- [EMA medicine opinions](https://spiral.ai/integrations/codex/ema-medicine-opinions)
- [Europe PMC article annotations](https://spiral.ai/integrations/codex/europe-pmc-article-annotations)
- [EMA medicine documents](https://spiral.ai/integrations/codex/ema-medicine-documents)
- [Europe PMC article details](https://spiral.ai/integrations/codex/europe-pmc-article-details)

## Questions about EMA medicines under evaluation in Codex

**Can Codex use EMA medicines under evaluation?**

Yes. Add Spiral to Codex as an MCP server, and Codex can find and run EMA medicines under evaluation like any built-in tool.

**How much does EMA medicines under evaluation cost in Codex?**

$0.00873 per call. You pay from your Spiral balance as you go, with no subscription, and a failed run is not charged. Your Codex plan is separate.

**Do I need an Alexandria account to use EMA medicines under evaluation in Codex?**

No. Spiral runs EMA medicines under evaluation on its own Alexandria account. You sign in to Spiral once and never paste a key.

**How long does it take to set up EMA medicines under evaluation in Codex?**

About two minutes: add the hosted server, then sign in.

**Does Codex wait while EMA medicines under evaluation runs?**

EMA medicines under evaluation runs in the background. Codex starts the run, checks on it and gives you the json when it's ready.

**Does EMA cover every medicine sold in Europe?**

The medicine export covers applications submitted through EMA's centralized procedure. Its shortage catalog covers EMA-assessed shortages, while national authorities also maintain country-specific shortage information.

**How often does EMA publish updated data?**

EMA rebuilds its website JSON exports at 06:00 and 18:00 Amsterdam time, while its list of human medicines under evaluation is monthly. Those source schedules do not establish when an endpoint refreshes its copy.

**Does an EMA record mean a medicine is authorized?**

No. EMA retains refused and withdrawn records, and a scientific opinion precedes the European Commission's legally binding authorization decision.

**Are all EMA documents available in every EU language?**

EMA publishes the public summary and product information in all official EU languages. That commitment does not extend to every document type, and the document export supplies translation links where available.

**Can EMA material be reused in a commercial report?**

EMA allows commercial and noncommercial reproduction of its material when EMA is acknowledged in each copy. Third-party content requires permission from its copyright holder.

